Home › Interstitial Lung Diseases › Florida › Naples
Interstitial Lung Diseases clinical trials in Naples, FL
5 studies for Interstitial Lung Diseases are looking for participants at sites in and around Naples (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
RecruitingPhase 3
- Essence MD Research, Naples
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingPhase 3
- USA006, Naples
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
RecruitingPhase 3
- GSK Investigational Site, Naples
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingObservational study
- NCH Research Institute, Naples
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RecruitingPhase 3
- USA006, Naples
About Interstitial Lung Diseases
Interstitial lung diseases are a group of diseases that inflame or scar the lungs. Breathing in particles (asbestosis, silicosis) causes some types.
More about Interstitial Lung Diseases on MedlinePlus
Interstitial Lung Diseases trials in other cities
- New York City, NY18 studies
- Philadelphia, PA16 studies
- Los Angeles, CA14 studies
- Durham, NC13 studies
- Kansas City, KS13 studies
- Charleston, SC13 studies
- Chicago, IL12 studies
- Houston, TX12 studies
- Aurora, CO11 studies
- Ann Arbor, MI11 studies
- Phoenix, AZ9 studies
- Salt Lake City, UT9 studies
Other studies in Naples
- Alzheimer's Disease7 studies
- Multiple Sclerosis4 studies
- Major Depressive Disorder4 studies
- Cardiovascular Disease4 studies
- Obesity4 studies
- Overweight4 studies
- Pulmonary Hypertension3 studies
- Atrial Fibrillation3 studies
- Heart Failure3 studies
- Aortic Valve Stenosis3 studies
- Parkinson's Disease3 studies
- Neurologic Diseases3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.